Hogan Lovells advised P-Cure in the authorization process. P-Cure, an Israeli med-tech company, in U.S. Food and Drug Administration (FDA) market clearance for a proton therapy...
P-Cure’s FDA Market Authorization of New Proton Therapy Device for Cancer Treatment
NONAGON’s FDA 510(k) Clearance For Smartphone Compatible Telehealth Device
Hogan Lovells advised NONAGON on the deal. NONAGON (previously named MyHomeDoc) through the U.S. Food and Drug Administration 510(k) clearance process for its N9 multisensory device...